Dr. Christopher L. Peters, MD

Dr. Peters practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Peters' NPI, 1407946023, was assigned on October 13, 2006. Dr. Peters graduated from University of Southern California Keck School of Medicine in 1988. Dr. Peters holds Utah license 181455-1205.

Dr. Peters' primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Peters' primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Peters is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Peters to 3 more group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peters practices, 6 sites in all. Vendor and product names are available with a free account.

Adult reconstructive orthopaedic surgery is Dr. Peters' primary specialty in the NPI Registry, under taxonomy code 207XS0114X. Dr. Peters is licensed in Utah.

CMS data shows 443 Medicare services from Dr. Peters across 9 procedure codes in 2024, for 232 Medicare patients. Medicare paid $131,823 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 232 Medicare patients who saw Dr. Peters in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have arthritis, and 66% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Peters' median patient age at 71, with 56% women.

In 2024, Dr. Peters wrote 55 Medicare Part D claims for 28 patients. 96% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $10 in total drug cost. In 2021, CMS named 108 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Peters for performance year 2024, reported as part of a group. Dr. Peters accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 75 procedures of knee replacement by Dr. Peters, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 179 papers to Dr. Peters, published from 2006 to 2025. 2017 was the busiest year, with 11. The most frequent topics are Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee and Acetabulum. Dr. Peters has published most often in J Arthroplasty. Dr. Peters' most frequent co-authors are Christopher Earl Pelt, MD, Stephen Kenji Aoki, MD and Michael J. Archibeck, MD.

Dmand AI links Dr. Peters to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Osteoarthritis, Hip, Hip Fractures and Bronchiolitis Obliterans Syndrome. Zimmer Biomet sponsors the most, 2.

CMS Open Payments shows 446 general payments to Dr. Peters from 8 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 83% of the total. Zimmer Biomet Holdings, Inc. paid the most, $10,318,671.

Dr. Peters graduated from University of Southern California Keck School of Medicine in 1988.